[1. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body weight and mortality among women. N Engl J Med. 1995; 333: 677-85.10.1056/NEJM1995091433311017637744]Search in Google Scholar
[2. Rosengren A, Wedel H, Wilhelmsen L. Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J. 1999; 20:269-77.10.1053/euhj.1998.1235]Search in Google Scholar
[3. Stears AJ, Byrne CD. Adipocyte metabolism and the metabolic syndrome. Diabetes Obes Metab. 2001; 3: 129-42.10.1046/j.1463-1326.2001.00151.x11412277]Search in Google Scholar
[4. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA. 2005; 102:10610-5.10.1073/pnas.0504703102118079916030142]Search in Google Scholar
[5. Kempf K, Rose B, Illig T, Rathmann W, Strassburger K, Thorand B, et al. Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: Results from the MONICA/ KORA studies. Exp Clin Endocrinol Diabetes. 2010; 118:184-9.10.1055/s-2008-108149918726871]Search in Google Scholar
[6. Kloting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schon MR, et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun. 2006; 339: 430-6.10.1016/j.bbrc.2005.11.03916298335]Search in Google Scholar
[7. Youn BS, Kloting N, Kratzsch J, Lee N, Park JW, Song ES, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes. 2008; 57:372-7.10.2337/db07-104517991760]Search in Google Scholar
[8. Gulcelik NE, Karakaya J, Gedik A, Usman A, Gurlek A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol. 2009; 160:65-70.10.1530/EJE-08-072318952766]Search in Google Scholar
[9. Ye Y, Hou XH, Pan XP, Lu JX, Jia WP. Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes. Chin Med J (Engl). 2009; 122:2530-3.]Search in Google Scholar
[10. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008; 31(Suppl 1):S55-60.10.2337/dc08-S05518165338]Search in Google Scholar
[11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499-502.10.1093/clinchem/18.6.499]Search in Google Scholar
[12. Seeger J, Ziegelmeier M, Bachmann A, Lossner U, Kratzsch J, Bluher M, et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab. 2008; 93:247-51.10.1210/jc.2007-185317956947]Search in Google Scholar
[13. Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes. 2008; 57:1501-7.10.2337/db08-012718375437]Search in Google Scholar
[14. Lee MK, Jekal Y, Im JA, Kim E, Lee SH, Park JH, et al. Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clin Chim Acta. 2010; 411:381-5.10.1016/j.cca.2009.12.00320018186]Search in Google Scholar